For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT05068349
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05068349
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05068349. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-07 (actual); primary completion 2025-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
- Condition
- Stroke
- Condition
- Cerebral Infarction
- Condition
- Brain Infarction
- Condition
- Brain Ischemia
- Condition
- Nervous System Diseases
- Condition
- Central Nervous System Diseases
- Condition
- Vascular Diseases
- Intervention (Drug)
- Butylphthalide
- Lead sponsor
- Qianfoshan Hospital
Record details
- Record id
cardio:ct-nct05068349- Content hash
59b83b692368887e503cfd50b4ca917ebb2fe828cd473bf0816cd916298d528e